首页> 美国卫生研究院文献>International Journal of Reproductive Biomedicine >Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: A non-randomized clinical trial
【2h】

Transvaginal perfusion of G-CSF for infertile women with thin endometrium in frozen ET program: A non-randomized clinical trial

机译:G-CSF经阴道灌注治疗不孕症子宫内膜薄的不育妇女的一项非随机临床试验

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: We often see patients with a thin endometrium in ART cycles, in spite of standard and adjuvant treatments. Improving endometrial growth in patients with a thin endometrium is very difficult. Without adequate endometrial thickness these patients, likely, would not have reached embryo transfer. >Objective: We planned this study to investigate the efficacy of intrauterine granulocyte colony-stimulating factor (G-CSF) perfusion in improving endometrium, and possibly pregnancy rates in frozen-thawed embryo transfer cycles. >Materials and Methods: This is a non-randomized intervention clinical trial. Among 68 infertile patients with thin endometrium (-7 mm) at the 12th-13th cycle day, 34 patients received G-CSF. G-CSF (300 microgram/1mL) to improve endometrial thickness was direct administered by slow intrauterine infusion using IUI catheter. If the endometrium had not reached at least a 7-mm within 48-72 h, a second infusion was given. Endometrial thickness was assessed by serial vaginal ultrasound at the most expanded area of the endometrial stripe. >Results: The cycle was cancelled in the patients with thin endometrium (endometrial thickness below 7mm) until 19th cycle day ultimately The cycle cancelation rate owing to thin endometrium was similar in G-CSF group (15.20%), followed by (15.20%) in the control group (p=1.00). The endometrial growth was not different within 2 groups, an improvement was shown between controlled and G-CSF cotreated groups, with chemical (39.30% vs. 14.30%) and clinical pregnancy rates (32.10% vs. 12.00%) although were not significant. >Conclusion: Our study fails to demonstrate that G-CSF has the potential to improve endometrial thickness but has the potential to improve chemical and clinical pregnancy rate of the infertile women with thin endometrium in frozen-thawed embryo transfer cycle.
机译:>背景:尽管进行了标准和辅助治疗,我们仍经常看到ART周期子宫内膜较薄的患者。子宫内膜薄的患者很难改善子宫内膜的生长。没有足够的子宫内膜厚度,这些患者很可能无法达到胚胎移植的目的。 >目的:我们计划进行这项研究,以研究子宫内粒细胞集落刺激因子(G-CSF)灌注改善子宫内膜的功效,并可能在冷冻融化的胚胎移植周期中提高妊娠率。 >材料和方法:这是一项非随机干预的临床试验。在第12个疗程日的68例不育子宫内膜薄(-7 mm)的不孕患者中,有34例接受了G-CSF治疗。使用IUI导管通过缓慢的子宫内输注直接给药以改善子宫内膜厚度的G-CSF(300微克/ 1mL)。如果子宫内膜在48-72小时内未达到至少7毫米,则应进行第二次输注。通过连续阴道超声在子宫内膜条纹的最大扩展区域评估子宫内膜厚度。 >结果:子宫内膜薄(子宫内膜厚度低于7mm)患者的周期被取消,直到第19个 周期,最终由于子宫内膜薄而导致的周期取消率与G相似。 -CSF组(15.20%),其次是对照组(15.20%)(p = 1.00)。两组的子宫内膜生长无差异,对照组和G-CSF联合治疗组之间的内膜生长无明显改善,其中化学疗法(39.30%vs. 14.30%)和临床妊娠率(32.10%vs. 12.00%)虽然不显着。 >结论:我们的研究未能证明G-CSF具有改善子宫内膜厚度的潜力,但有可能改善冷冻解冻胚胎移植周期中子宫内膜薄的不育女性的化学和临床妊娠率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号